| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma
|
Waidhauser, Johanna
|
|
|
71 |
8 |
p. 1937-1947
|
artikel
|
| 2 |
A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma
|
Kiyohara, Eiji
|
|
|
71 |
8 |
p. 2041-2049
|
artikel
|
| 3 |
A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer
|
Zuo, Bangyou
|
|
|
71 |
8 |
p. 1889-1896
|
artikel
|
| 4 |
Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis
|
Cheung, Yee-Ming Melody
|
|
|
71 |
8 |
p. 1795-1812
|
artikel
|
| 5 |
Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice
|
Gaignage, Mélanie
|
|
|
71 |
8 |
p. 1851-1862
|
artikel
|
| 6 |
Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma
|
Gartrell, Robyn D.
|
|
|
71 |
8 |
p. 1837-1849
|
artikel
|
| 7 |
Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells
|
Liao, Fei
|
|
|
71 |
8 |
p. 1959-1973
|
artikel
|
| 8 |
Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence
|
Czarnecka, Anna Małgorzata
|
|
|
71 |
8 |
p. 1949-1958
|
artikel
|
| 9 |
Functional virus-specific memory T cells survey glioblastoma
|
Ning, Jianfang
|
|
|
71 |
8 |
p. 1863-1875
|
artikel
|
| 10 |
Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells
|
Cluff, Emily
|
|
|
71 |
8 |
p. 1989-2005
|
artikel
|
| 11 |
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
|
Strobel, Sophia B.
|
|
|
71 |
8 |
p. 2051-2056
|
artikel
|
| 12 |
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer
|
Salomon, Nadja
|
|
|
71 |
8 |
p. 1975-1988
|
artikel
|
| 13 |
Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia
|
Roversi, Fernanda Marconi
|
|
|
71 |
8 |
p. 1909-1921
|
artikel
|
| 14 |
Oral administration of a whole glucan particle (WGP)-based therapeutic cancer vaccine targeting macrophages inhibits tumor growth
|
He, Liuyang
|
|
|
71 |
8 |
p. 2007-2028
|
artikel
|
| 15 |
Pediatric glioblastoma: mechanisms of immune evasion and potential therapeutic opportunities
|
Njonkou, Rosy
|
|
|
71 |
8 |
p. 1813-1822
|
artikel
|
| 16 |
Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma
|
Xu, Wenhao
|
|
|
71 |
8 |
p. 1923-1935
|
artikel
|
| 17 |
Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial
|
Gong, Jifang
|
|
|
71 |
8 |
p. 1897-1908
|
artikel
|
| 18 |
Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy
|
Okada, Ryuhei
|
|
|
71 |
8 |
p. 1877-1887
|
artikel
|
| 19 |
The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents
|
Zamora Atenza, Carlos
|
|
|
71 |
8 |
p. 1823-1835
|
artikel
|
| 20 |
Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden
|
Femel, Julia
|
|
|
71 |
8 |
p. 2029-2040
|
artikel
|
Tijdschrift beschrijving